George Lundberg, MD Editor in Chief at Cancer Commons
-
October 22, 2020
ESMO 2019: Immunotherapy in Cervical and Endometrial Cancers Bookmark
George Lundberg, MDArticle from The ASCO Post curated by Contributing Editor George Lundberg, MD, who notes:
Recent clinical trial results show that immunotherapy—a type of treatment that boosts the immune system to fight cancer—provided long-lasting, improved outcomes for patients with advanced cervical or endometrial cancer. These are important findings for difficult-to-treat cancers.
.
-
October 22, 2020
Malignant Melanoma Treatment & Management Bookmark
George Lundberg, MDOverview from Medscape curated by Contributing Editor George Lundberg, MD, who notes:
The dramatic array of treatment options now available for this serious disease is nicely summarized in this review. (Free registration required, written with a physician audience in mind.)
.
-
October 22, 2020
Cervical Cancer—An Overview Bookmark
George Lundberg, MDOverview from Medscape curated by Contributing Editor George Lundberg, MD.
Cervical cancer can be detected early, but when it is fully developed it requires advanced treatment approaches. This comprehensive review outlines treatment options. (Free registration required, written with a physician audience in mind.)
.
-
October 16, 2020
Molecular Profiling in Metastatic Colorectal Cancer Bookmark
George Lundberg, MDArticle from the academic journal Oncology, curated by Contributing Editor George Lundberg, MD, who notes:
Molecular testing is essential to guide effective treatment in metastatic colorectal cancer. This academic review article provides a good overview of the topic.
.
-
October 16, 2020
Lymphoblastic Lymphoma—An Overview Bookmark
George Lundberg, MDOverview from Medscape curated by Contributing Editor George Lundberg, MD, who notes:
This 2019 comprehensive presentation of lymphoblastic (precursor B-cell and T-cell) lymphoma emphasizes lymph node-predominant involvement in this blood-lymph node diaspora. (Free registration required, written with a physician audience in mind.)
.
-
October 16, 2020
Hodgkin Lymphoma—An Overview Bookmark
George Lundberg, MDOverview from Medscape curated by Contributing Editor George Lundberg, MD, who notes:
This 2020 encyclopedic approach to a potentially curable form of lymphoma is richly detailed and specific for all types and stages of Hodgkin lymphoma. (Free registration required, written with a physician audience in mind.)
.
-
October 10, 2020
NCCN Guidelines for Patients: Acute Myeloid Leukemia Bookmark
George Lundberg, MDPDF from the National Comprehensive Cancer Network curated by Contributing Editor George Lundberg, MD, who notes:
The National Comprehensive Cancer Network (NCCN) has issued a 2020 edition of its Guidelines for Patients about acute myeloid leukemia.
Go to full document published by the NCCN.
.
-
October 10, 2020
Novel Developments in the Multimodality Treatment of Esophageal Cancer Bookmark
George Lundberg, MDA special issue of the research journal Annals of Esophagus curated by Contributing Editor George Lundberg, MD.
This special issue of an academic research journal discusses “multimodality” treatment—the combination of more than one treatment—and how it is used to treat advanced esophageal cancer.
.
-
October 8, 2020
Innovent Biologics’s TYVYT/Byvasda combo shows survival benefit in late-stage liver cancer study Bookmark
George Lundberg, MDArticle from Seeking Alpha curated by Contributing Editor George Lundberg, MD, who notes:
In a phase 3 clinical trial, a new drug combination improved both overall survival and progression-free survival for people with hepatocellular carcinoma.
.
-
October 8, 2020
Preliminary Results of Two Large Immune Therapy Studies Show Promise in Advanced Cervical Cancer Bookmark
George Lundberg, MDPress release from Ohio State University Wexner Medical Center curated by Contributing Editor George Lundberg, MD.
This press release outlines promising preliminary results from two phase 2 clinical trials testing the drug balstilimab alone or in combination with zalifrelimab.
.